# PDSS1

## Overview
The PDSS1 gene encodes the protein decaprenyl diphosphate synthase subunit 1, which is a crucial enzyme in the biosynthesis of coenzyme Q10 (CoQ10) in humans. This protein is categorized as a polyprenyl transferase and plays a significant role in the elongation of the prenyl side chain of coenzyme Q, a vital step in the quinone biosynthesis pathway. CoQ10 is an essential component of the mitochondrial electron transport chain, contributing to oxidative phosphorylation and cellular energy production. The PDSS1 protein forms a heterotetrameric complex with PDSS2, which is necessary for the synthesis of ubiquinone, underscoring its importance in mitochondrial function and energy metabolism (Wang2012Molecular; Mollet2007Prenyldiphosphate). Mutations in the PDSS1 gene can lead to primary coenzyme Q10 deficiency, a condition with diverse clinical manifestations, highlighting the gene's critical role in human health (Mollet2007Prenyldiphosphate).

## Structure
The PDSS1 gene encodes the decaprenyl diphosphate synthase subunit 1, a key enzyme in the biosynthesis of coenzyme Q10. The protein is part of the polyprenyl transferase family and features a conserved polyprenyl synthase domain. This domain is characterized by regions rich in aspartic acid, which are crucial for its catalytic activity and substrate binding (Mollet2007Prenyldiphosphate).

The secondary structure of PDSS1 includes alpha-helices and beta-sheets, which contribute to its overall stability and function. These structural elements are typical of prenyltransferases, which often have a 'terpenoid synthase fold' composed of multiple alpha helices (Liang2002Structure). The tertiary structure likely involves a central cavity surrounded by these helices, facilitating substrate interaction and catalysis (Liang2002Structure).

PDSS1 can form a heterotetramer with PDSS2, indicating a quaternary structure that is essential for its function in CoQ10 synthesis (Nardecchia2020Missense). Post-translational modifications such as phosphorylation may occur, affecting the protein's activity and interactions. Splice variant isoforms of PDSS1 may exist, potentially influencing its function and cellular localization. However, specific details on these variants are not provided in the available context.

## Function
The PDSS1 gene encodes the prenyldiphosphate synthase, subunit 1, which is a key enzyme in the biosynthesis of coenzyme Q10 (CoQ10) in humans. This enzyme is responsible for the elongation of the prenyl side chain of coenzyme Q in the quinone biosynthesis pathway, a crucial step for the production of ubiquinone (Mollet2007Prenyldiphosphate). Ubiquinone is an essential component of the mitochondrial electron transport chain, playing a vital role in oxidative phosphorylation and energy production in cells (Mollet2007Prenyldiphosphate). 

In healthy human cells, the PDSS1 gene ensures the proper synthesis of CoQ10, which is critical for maintaining efficient energy production through oxidative phosphorylation (Mollet2007Prenyldiphosphate). CoQ10 also functions as a transmembrane hydrogen carrier and is important for antioxidant defenses (Mollet2007Prenyldiphosphate). The PDSS1 gene, along with PDSS2, forms a heterotetrameric enzyme complex necessary for the synthesis of ubiquinone, highlighting its crucial role in cellular energy production and mitochondrial function (Wang2012Molecular).

## Clinical Significance
Mutations in the PDSS1 gene are associated with primary coenzyme Q10 deficiency, a rare autosomal recessive condition that can lead to a variety of clinical manifestations. One notable mutation is a homozygous T→G transversion at nucleotide 977 in exon 10, resulting in the substitution of aspartic acid with glutamic acid (D308E). This mutation impairs the function of prenyldiphosphate synthase, crucial for the biosynthesis of coenzyme Q10 (CoQ10), leading to its deficiency (Mollet2007Prenyldiphosphate).

CoQ10 deficiency due to PDSS1 mutations can manifest in several clinical forms, including an encephalomyopathic form characterized by exercise intolerance and ataxia, a generalized infantile variant with severe encephalopathy and renal disease, and an ataxic form with seizures and cerebral atrophy (Mollet2007Prenyldiphosphate). The deficiency affects oxidative phosphorylation, although some residual respiratory chain function may be maintained due to trace amounts of CoQ10 or normal levels of CoQ9 (Mollet2007Prenyldiphosphate).

The clinical heterogeneity of CoQ10 deficiency suggests genetic heterogeneity, possibly due to the involvement of multiple enzymes and genes in its biosynthesis (Mollet2007Prenyldiphosphate).

## Interactions
PDSS1, or decaprenyl diphosphate synthase subunit 1, is involved in several protein interactions crucial for its function in coenzyme Q biosynthesis. PDSS1 forms a heterotetramer with PDSS2, which is essential for the synthesis of polyprenyl diphosphate, a precursor in the ubiquinone biosynthesis pathway (Saiki2008Coenzyme). This interaction is significant for the production of coenzyme Q, as both PDSS1 and PDSS2 are required for the elongation of the prenyl side chain (Saiki2008Coenzyme).

PDSS1 also interacts with various COQ proteins, playing a role in maintaining their stability. Knockdown studies have shown that reducing PDSS1 levels leads to decreased levels of COQ4, COQ5, COQ6, and COQ7, indicating that PDSS1 is crucial for the stability of these proteins within the mitochondrial fraction (Yen2020Characterization). The presence of PDSS1 in protein complexes with COQ proteins suggests its involvement in a larger multiprotein complex necessary for coenzyme Q biosynthesis (Yen2020Characterization).

Additionally, PDSS1 is implicated in interactions related to cancer pathways, particularly through the STAT3 signaling pathway, where it may influence cell cycle progression and tumor development (Rao2022A).


## References


[1. (Mollet2007Prenyldiphosphate) Julie Mollet, Irina Giurgea, Dimitri Schlemmer, Gustav Dallner, Dominique Chretien, Agnès Delahodde, Delphine Bacq, Pascale de Lonlay, Arnold Munnich, and Agnès Rötig. Prenyldiphosphate synthase, subunit 1 (pdss1) and oh-benzoate polyprenyltransferase (coq2) mutations in ubiquinone deficiency and oxidative phosphorylation disorders. Journal of Clinical Investigation, 117(3):765–772, March 2007. URL: http://dx.doi.org/10.1172/jci29089, doi:10.1172/jci29089. This article has 214 citations and is from a highest quality peer-reviewed journal.](https://doi.org/10.1172/jci29089)

[2. (Saiki2008Coenzyme) Ryoichi Saiki, Adam L. Lunceford, Yuchen Shi, Beth Marbois, Rhonda King, Justin Pachuski, Makoto Kawamukai, David L. Gasser, and Catherine F. Clarke. Coenzyme q10 supplementation rescues renal disease in pdss2kd/kd mice with mutations in prenyl diphosphate synthase subunit 2. American Journal of Physiology-Renal Physiology, 295(5):F1535–F1544, November 2008. URL: http://dx.doi.org/10.1152/ajprenal.90445.2008, doi:10.1152/ajprenal.90445.2008. This article has 80 citations and is from a peer-reviewed journal.](https://doi.org/10.1152/ajprenal.90445.2008)

[3. (Liang2002Structure) Po‐Huang Liang, Tzu‐Ping Ko, and Andrew H.‐J Wang. Structure, mechanism and function of prenyltransferases. European Journal of Biochemistry, 269(14):3339–3354, July 2002. URL: http://dx.doi.org/10.1046/j.1432-1033.2002.03014.x, doi:10.1046/j.1432-1033.2002.03014.x. This article has 349 citations.](https://doi.org/10.1046/j.1432-1033.2002.03014.x)

[4. (Rao2022A) Zuqin Rao, Heng Li, Wenchao Yao, Qiang Wang, Biao Ma, Dongbo Xue, and Xianzhi Meng. A novel hcc prognosis predictor pdss1 affects the cell cycle through the stat3 signaling pathway in hcc. Frontiers in Oncology, July 2022. URL: http://dx.doi.org/10.3389/fonc.2022.927468, doi:10.3389/fonc.2022.927468. This article has 0 citations and is from a peer-reviewed journal.](https://doi.org/10.3389/fonc.2022.927468)

[5. (Wang2012Molecular) Ying Wang and Siegfried Hekimi. Molecular genetics of ubiquinone biosynthesis in animals. Critical Reviews in Biochemistry and Molecular Biology, 48(1):69–88, November 2012. URL: http://dx.doi.org/10.3109/10409238.2012.741564, doi:10.3109/10409238.2012.741564. This article has 56 citations and is from a peer-reviewed journal.](https://doi.org/10.3109/10409238.2012.741564)

[6. (Nardecchia2020Missense) Francesca Nardecchia, Agnese De Giorgi, Flavia Palombo, Claudio Fiorini, Anna M. De Negri, Valerio Carelli, Leonardo Caporali, and Vincenzo Leuzzi. Missense pdss1 mutations in coenzymeq10 synthesis cause optic atrophy and sensorineural deafness. Annals of Clinical and Translational Neurology, 8(1):247–251, December 2020. URL: http://dx.doi.org/10.1002/acn3.51232, doi:10.1002/acn3.51232. This article has 9 citations and is from a peer-reviewed journal.](https://doi.org/10.1002/acn3.51232)

[7. (Yen2020Characterization) Hsiu-Chuan Yen, Wen-Yu Yeh, Szu-Hsien Lee, Yu-Hsiu Feng, and Si-Ling Yang. Characterization of human mitochondrial pdss and coq proteins and their roles in maintaining coenzyme q10 levels and each other’s stability. Biochimica et Biophysica Acta (BBA) - Bioenergetics, 1861(7):148192, July 2020. URL: http://dx.doi.org/10.1016/j.bbabio.2020.148192, doi:10.1016/j.bbabio.2020.148192. This article has 17 citations.](https://doi.org/10.1016/j.bbabio.2020.148192)